Valuation Piper Sandler Companies Berne S.E.
Stocks
PJR
US7240781002
Investment Banking & Brokerage Services
|
Delayed
Berne S.E.
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
| 08-12 | Outlook Therapeutics Starts Public Offering of Stock, Warrants | MT |
| 08-07 | Doximity set for biggest daily jump ever as investors bet on AI optimism | RE |
Company Valuation: Piper Sandler Companies
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,520 | 1,778 | 2,644 | 4,782 | 6,009 | 5,406 | - | - |
| Change | - | -29.42% | 48.7% | 80.84% | 25.66% | -10.04% | - | - |
| Enterprise Value (EV) 1 | 1,763 | 1,647 | 2,355 | 4,309 | 5,215 | 4,580 | 4,500 | 4,415 |
| Change | - | -6.57% | 42.95% | 82.98% | 21.02% | -12.17% | -1.76% | -1.88% |
| P/E | 10.9x | - | - | - | 21.5x | 16.7x | 14.1x | - |
| PBR | 2.37x | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | 1.1x | 0.8x | - |
| Capitalization / Revenue | 1.27x | 1.24x | 1.99x | 3.1x | 3.2x | 2.6x | 2.3x | 2.16x |
| EV / Revenue | 0.89x | 1.15x | 1.77x | 2.8x | 2.78x | 2.2x | 1.92x | 1.76x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 3.21x | 6.12x | 11.1x | 14.2x | 12.7x | 9.89x | 8.27x | 7.36x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.4875 | 0.9125 | 0.85 | 1.375 | 1.925 | 2.185 | 2.02 | 2.36 |
| Rate of return | 1.09% | 2.8% | 1.94% | 1.83% | 2.27% | 2.86% | 2.64% | 3.08% |
| EPS 2 | 4.108 | - | - | - | 3.955 | 4.58 | 5.42 | - |
| Distribution rate | 11.9% | - | - | - | 48.7% | 47.7% | 37.3% | - |
| Net sales 1 | 1,980 | 1,434 | 1,330 | 1,541 | 1,879 | 2,082 | 2,349 | 2,506 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | 550 | 269.2 | 212.9 | 303.7 | 410.7 | 462.9 | 544.4 | 599.5 |
| Net income 1 | - | - | - | - | 281.3 | 317.4 | 367.1 | - |
| Net Debt 1 | -756.3 | -130.9 | -289.4 | -472.8 | -794.4 | -825.9 | -906.6 | -991.3 |
| Reference price 2 | 44.63 | 32.55 | 43.72 | 74.99 | 84.93 | 76.50 | 76.50 | 76.50 |
| Nbr of stocks (in thousands) | 56,459 | 54,638 | 60,489 | 63,771 | 70,758 | 70,670 | - | - |
| Announcement Date | 2/10/22 | 2/3/23 | 2/2/24 | 1/31/25 | 2/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 9.75x | 7.19x | 11.53x | 3.33% | 46.91B | |
| 6.06x | - | - | 1.47% | 12.86B | |
| 17.89x | 3.41x | 11.8x | 2.14% | 8.99B | |
| 20.51x | 10.15x | 14.27x | 3.68% | 6.63B | |
| 14.27x | - | - | 7.38% | 5.5B | |
| 16.7x | 2.2x | - | 2.86% | 5.41B | |
| 23.28x | 2.68x | 12.7x | 3.8% | 5.07B | |
| 36.21x | 2.22x | 9.83x | 0.57% | 4.46B | |
| Average | 18.08x | 4.64x | 12.03x | 3.15% | 11.98B | |
| Weighted average by Cap. | 13.36x | 6.08x | 11.79x | 3.1% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PIPR Stock
- PJR Stock
- Valuation Piper Sandler Companies
Select your edition
All financial news and data tailored to specific country editions
